Cargando…
The clinical impact of coronavirus infection in patients with hematologic malignancies and hematopoietic stem cell transplant recipients
BACKGROUND: Compared to other respiratory viruses, relatively little is known about the clinical impact of coronavirus (CoV) infection after hematopoietic stem cell transplant (HSCT) or in patients with hematologic malignancies. OBJECTIVES: To characterize the role of CoV in respiratory tract infect...
Autores principales: | Hakki, Morgan, Rattray, Rogan M., Press, Richard D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106547/ https://www.ncbi.nlm.nih.gov/pubmed/26071326 http://dx.doi.org/10.1016/j.jcv.2015.04.012 |
Ejemplares similares
-
2278. Emergence of Resistance and Associated Mortality during Persistent Pseudomonas aeruginosa Bacteremia in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients
por: Fontana, Lauren, et al.
Publicado: (2019) -
Long-Term Dominance of Carbapenem-Non-Susceptible Pseudomonas aeruginosa ST111 in Hematologic Malignancy Patients and Hematopoietic Cell Transplant Recipients
por: Zhang, Liyang, et al.
Publicado: (2022) -
Coronavirus Infection in Hematopoietic Stem Cell Transplant Recipients
por: Eichenberger, Emily, et al.
Publicado: (2017) -
Clinical Significance of Human Coronavirus in Bronchoalveolar Lavage Samples From Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies
por: Ogimi, Chikara, et al.
Publicado: (2017) -
Clinical Significance of Human Coronavirus in Bronchoalveolar Lavage Samples From Hematopoietic Cell Transplantation Recipients and Hematologic Malignancy Patients
por: Ogimi, Chikara, et al.
Publicado: (2016)